NCT04497272View on ClinicalTrials.gov

Assesment of the Metabolomic Signature in COVID-19 Patients

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

August 7, 2020

Primary Completion Date

March 1, 2021

Study Completion Date

July 31, 2022

Conditions
COVID 19
Interventions
OTHER

COVID-19 patients

It will consist in the collection of 1 additional tubes at their blood draw and 1 urine sample.

Trial Locations (1)

06001

CHU de nice, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT04497272 - Assesment of the Metabolomic Signature in COVID-19 Patients | Biotech Hunter | Biotech Hunter